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ABSTRACT 
Context: Military recruits and elite athletes are susceptible to stress fracture injuries. 
Genetic predisposition has been postulated to have a role in their development. The 
P2X7 receptor (P2X7R) gene, a key regulator of bone remodelling, is a genetic 
candidate  that may contribute to stress fracture predisposition. 
Objective: To evaluate the putative contribution of P2X7R to stress fracture injury in 
two separate cohorts, military personnel and elite athletes.  
Methods: In 210 Israeli Defence Forces (IDF) military conscripts, stress fracture 
injury was diagnosed (n=43) based on symptoms and a positive bone scan. In a 
separate cohort of 518 elite athletes, self-reported medical imaging scan-certified 
stress fracture injuries were recorded (n=125). Non-stress fracture controls were 
identified from these cohorts who had a normal bone scan or no history or symptoms 
of stress fracture injury. Study participants were genotyped for functional SNPs 
within the P2X7R gene using proprietary fluorescence-based competitive allele-
specific PCR assay. Pearson Chi-square (χ2) tests, corrected for multiple 
comparisons, were used to assess associations in genotype frequencies.  
Results: The variant allele of P2X7R SNP rs3751143 (Glu496Ala- loss of function) 
was associated with stress fracture injury, while  the variant allele of  rs1718119 
(Ala348Thr- gain of function) was associated with a reduced occurrence of  stress 
fracture injury in military conscripts (P<0.05).  The association of the variant allele of 
rs3751143 with stress fractures was replicated in elite athletes (P<0.05), whereas the 
variant allele of rs1718119 was also associated with reduced multiple stress fracture 
cases in elite athletes (P<0.05).  
Conclusions: The association between independent P2X7R polymorphisms with stress 
fracture prevalence supports the role of a genetic predisposition in the development of 
stress fracture injury. 
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INTRODUCTION 
 
The lifetime incidence of stress fracture injury in military recruits and elite athletes 
has been reported to range from 1 to 24% [1,2] and can present at various skeletal 
sites, most commonly in the lower limbs [3]. Stress fractures are typically caused by 
excessive repeated mechanical loading applied in a rhythmic, sub-threshold manner 
[4], although the exact pathophysiology is not fully understood [5]. Inadequate bone 
remodelling can contribute to the development of stress fracture injury [6], alongside 
a number of environmental risk factors, including diet and nutrition, training status, 
training environment and individual biomechanics [7,8]. A genetic contribution to 
stress fracture risk is likely given that certain individuals present with multiple stress 
fractures at various skeletal sites [9], comparable stress fracture injuries occurring in 
monozygotic twins [10], high stress fracture recurrence rates [11], variable stress 
fracture incidence in military recruits who are exposed to equivalent training loads 
[12], and candidate gene studies investigating stress fracture prevalence [13-17]. 
 
The highly polymorphic purinergic P2X7 receptor (P2X7R) is a potential candidate to 
mediate stress fracture susceptibility due to previous associations with bone 
phenotypes [18,19,]. P2X7R is expressed by osteoblasts and osteoclasts in vitro [20], 
with receptor activation causing distinct cellular responses that include apoptosis [18] 
and increased cell permeability in osteoclasts [18] and osteoblasts [21]. These roles 
for P2X7R are supported by P2X7R-knockout (KO) murine models [22], where 
decreased bone mass [23], inflammatory response [24] and mechanical loading 
induced inter cell signalling [19] have been reported in the KO compared to wildtype 
(WT) animals. However, when whole-exome sequencing was employed to investigate 
genetic associations with stress fracture injury in military recruits, no significant 
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associations with P2X7R gene were shown [17]. The reason for this may be due to the 
relatively modest sample size (cases = 34, controls = 60) resulting in insufficient 
power to detect associations with stress fracture injury. Alternatively, the 
methodology for exome capture or sequencing may have been suboptimal to capture 
and cover the P2X7R gene region. 
 
Overall, 15 functional SNPs (http://www.ncbi.nlm.nih.gov/snp access date 12th 
February 2015; for SNP locations[18]), leading to either the gain or loss of function of 
the P2X7R protein, have been identified and several SNPs have been associated with 
bone phenotypic alterations including bone loss [25,26], lower bone mineral density 
(BMD) at the hip and lumbar spine [26,27], fracture risk [18] and overall osteoporosis 
risk [27,28]. 
 
To date, no studies have specifically investigated P2X7R SNPs in relation to stress 
fracture injury prevalence. We hypothesised that functional SNPs in P2X7R may play 
a role in stress fracture pathogenesis. Twelve functional SNPs, believed to be 
associated with bone phenotypes, were analysed in a cohort of military recruits with 
stress fractures; five of these SNPs were selected based on the results from the 
military cohort and previous literature related to P2X7R SNPs and bone phenotypes. 
The SNPs were then validated in an independently recruited, ethnically distinct cohort 
of elite athletes with stress fractures.    
 
METHODS 
Military Participants  
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Two hundred and ten active-duty Israel Defense Force (IDF) soldiers (197 men, 13 
women; see Table 1 for participant characteristics), who were referred to the Central 
Orthopaedic Clinic of the IDF with symptoms of stress fracture injury, volunteered to 
participate in the study. Stress fracture injuries were diagnosed following evaluation 
by an orthopaedic surgeon and a bone scan based on the standard protocol and criteria 
adopted in the IDF [29]. Participants were classified as either having no evidence of 
acute stress fracture injury or having acute stress fractures based on previously 
described criteria [30]. Due to the high rate of low-grade bone stress lesions (bone 
marrow oedema and/or periostitis without cortical fracture) and to facilitate focusing 
on clinically relevant stress fractures bone stress lesions without fracture, and 
metatarsal stress fractures were excluded from the study. Participants classified as not 
having stress fractures, confirmed by bone scan, were considered control participants. 
The study was approved by the Israeli Medical Corps Ethics Committee and each 
participant provided written informed consent prior to their involvement in the study. 
 
Elite Athlete Participants  
In total, 518 elite athletes (449 men and 69 women, Table 1) volunteered to 
participate in this study forming the Stress Fracture Elite Athlete (SFEA) cohort. 
Participants were recruited from the United Kingdom and North America and were 
mainly white Caucasian (83.2% in the stress fracture Cases and 79.9% in the non-
stress fracture Controls). Those suffering a stress fracture confirmed by medical 
imaging (Computerised Tomography (CT), Magnetic Resonance Imaging (MRI), X-
rays or bone scan) were cases, and those never having had a stress fracture or 
indicative symptoms formed the control group. In 17 athletes there was a lack of 
stress fracture history clarity (e.g., reports of stress lesions and suspected stress 
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fractures that were not confirmed by medical imaging) and thus these participants 
were removed from the statistical analysis. Due to the low number of female subjects, 
the male athletes were stratified into a male only cohort and cases of multiple stress 
fractures (more than one discrete occurrence at any site) for the purposes of analyses. 
Information on the SFEA cohort has been reported previously [31]. Ethical approval 
was granted by the Nottingham Trent University Ethical Review Committee and each 
participant provided written informed consent prior to their involvement in the study. 
Data collection in both cohorts was in line with the ethical standards set by the 1964 
declaration of Helsinki.  
 
DNA extraction  
From military participants, DNA was extracted from peripheral blood leukocytes 
using the PureGen1 kit (Gentra Inc., Minneapolis, MN, USA) according to the 
manufacturer instructions. From the elite athletes, genomic DNA was derived from 
saliva deposited into a 5 mL collection tube and subsequently mixed with 2 mL of 
preservative in accordance with manufacturer guidelines (Norgen Biotek Corp, Saliva 
DNA Collection kit Thorold, Canada).  
 
Genotyping 
Selection of functional SNPs was based upon previous studies, reporting significant 
associations between the P2X7R gene and bone phenotypes [18, 25-28]. In both 
cohorts genotyping of the P2X7R gene were performed by LGC genomics (Herts, 
UK) using proprietary fluorescence-based competitive allele-specific polymerase 
chain reaction assay. Twelve SNPs were examined in military conscripts and five 
were down selected for analysis in the elite athletes based on prior research detailing 
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an association with bone phenotypes (Table 2). LGC genomics laboratory staff was 
blinded to the clinical status (case or control) of the genotyped individuals.  
 
Statistical Analysis  
Statistical analyses were performed using statistical package SPSS version 21.0 
(SPSS, Inc., Chicago, IL, USA). Student’s t-test was used for analysis of descriptive 
variables. For all data, the Pearson Chi-square (χ2) test was used to assess 
associations in genotype frequencies and to assess the observed frequency of each 
genotype with what would be expected in accordance with Hardy-Weinberg 
equilibrium. The Benjamini and Hochberg False Discovery Rate Test [32] was 
applied in order to account for multiple comparisons of SNPs in both studies. 
Acceptable level of significance was classified as P<0.05.    
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RESULTS 
P2X7R SNPs and stress fracture occurrence 
Information for the SNPs genotyped along with the minor allele frequencies and call 
rates for both studies are shown in Table 2. All SNPs (from both studies) were shown 
to be in Hardy-Weinberg Equilibrium, except for rs2230912 and rs3751143 (P<0.05) 
in the military cohort.  
 
Military cohort  
Analysis of 12 P2X7R SNPs in the military cohort showed that the frequency of the 
gain of function A allele of SNP rs1718119 (combined and male only, Figure 1) and 
the loss of function C allele of SNP rs3751143 (male only) were significantly 
associated with stress fracture injury occurrence (P<0.05) (Table 3). Analysis of 
rs3751143 in men only showed that individuals carrying at least one loss of function 
alleles (C) were more likely to suffer from stress fractures (P=0.04) (Figure 1;Table 
3). Homozygosity for the A allele of rs1718119 was under represented in the stress 
fracture control population (5.4% in stress fracture sufferers compared to 17.7% in the 
non-stress fractures cohort) (P=0.01) (Table 3). No other SNP was significantly 
associated with stress fracture occurrence (P>0.05). After correcting for multiple 
comparisons using the False Discovery Rate (FDR) Test (Benjamini and Hochberg 
1995), none of the findings remained significant (P>0.05).  
 
Elite Athletes 
Analysis of five P2X7R SNPs in the SFEA cohort showed that while rs1718119 was 
not associated with single stress fracture prevalence (P=0.34) in elite athletes (Figure 
1), a significant association with multiple stress fracture injury in comparison to the 
non-stress fracture cohort was shown (P=0.01) (Table 4). Homozygotes for the A 
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allele of rs1718119 were present in only 2.4% of the multiple stress fracture cohort in 
comparison to 18.9% of the non-stress fracture group. The frequency of the A allele  
was also significantly decreased in the multiple stress fracture group (P<0.01). The 
frequency of the C allele of rs3751143 was associated with stress fracture prevalence 
(Table 3) (P=0.05). No association with stress fracture injury prevalence was seen in 
rs208294, rs2230912 or rs1653624 (Table 3). Combining homozygotes for the rare 
allele with heterozygotes showed no differences in either cohort for all SNPs 
investigated (data not shown). After correcting for multiple comparisons using the 
FDR test, none of the data remained significant (P>0.05).  
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DISCUSSION 
 
The findings from these two distinct populations are the first to demonstrate an 
independent association between stress fracture injury and functional polymorphisms 
(rs3751143 and rs1718119- linkage disequilibrium was not shown in either cohort) in 
the P2X7R gene. These independent associations are confirmed in two ethnically 
distinct populations and under conditions of different aetiologies of injury, although it 
should be noted that these associations were diminished following testing for multiple 
comparisons. The rs3751143 and rs1718119 SNPs have however, been consistently 
shown to be associated with bone phenotypes and clinical outcomes in older 
populations [18,25,27,28]. The mechanisms by which sequence variants in P2X7R 
may be involved in stress fracture injury occurrence are unknown, although 
rs3751143 and rs1718119 have been shown to have effects on receptor functioning 
[18,33] and human bone adaptations [28]. These effects on bone remodelling and 
cellular processes are plausible contributors to the putative association shown here 
between these variants and stress fracture injury occurrence.  
 
P2X7Rs are expressed in all bone cells, and for this reason the specific mechanisms of 
how the P2X7Rs influence stress fracture injury is difficult to distinguish and is most 
likely multi-factorial. The pathophysiology of stress fracture injury is related to the 
bone failing to adapt to repetitive loading cycles causing damage to bone micro-
architecture and resultant bone weakness [8]. As a result of allelic variations in 
P2X7R SNPs, impairment in sensitivity to mechanical loading may cause genotype 
specific alterations in mechanotransduction [19]. 
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Whilst the bone phenotypic consequences of allelic variations in the rs3751143 and 
rs1718119 are reported in osteoporotic or older individuals, this has not been explored 
in young populations with stress fracture injury. It is highly likely that the aetiology of 
stress fracture injury would be different to the aetiology of bone disease, which may 
lead to each SNP being associated with different phenotypic outcomes.  In rs3751143, 
the loss of function variant also has bone phenotypic consequences. In vitro, the 
rs3751143 variant is associated with osteoclast apoptosis [18], reduced pore formation 
[34] and reduced pro-inflammatory cytokine secretion [35]. In vivo, lower lumbar 
spine BMD [28] and an increased risk of fracture have been shown [18]. The 
rs1718119 polymorphism results in increased receptor functioning related to 
monocyte activation and increases interleukin-1 alpha and beta release from 
monocytes and macrophages [33]. Recent in vivo studies have shown that the 
rs1718119 variant may also be related to bone phenotypes, including increased BMD 
in middle aged (≥50y) and osteoporotic men and women [27,28], and a reduced 
susceptibility to vertebral fracture in post-menopausal women and osteoporotic men 
and women [25,28].  
     
 
Although the rs3751143 and rs1718119 SNPs were independently associated with 
increased stress fracture injury prevalence in both cohorts, other SNPs within the 
P2X7R gene were not, despite evidence that rs28360447, rs28360457, rs2230912 and 
rs1653624 are associated with bone phenotypic changes [25,28,33]. The lack of 
association may be due to the variability in the anatomical sites where stress fractures 
were sustained, it is possible that specific SNPs might influence stress fracture risk at 
different anatomical sites. There might also have been a minimal or no effect of these 
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SNPs on  stress fracture injury predisposition compared with the previous highlighted 
associations with osteoporosis and fragility fractures [18,27,28].  
 
Although the number of genotyped individuals was higher than previously published 
studies exploring genetic associations with stress fracture prevalence [13-17], there 
are some limitations to this study. After correcting for multiple comparisons, the 
results did not remain significant. However, the conservative nature of multiple 
comparison testing increases the occurrence of a type II error. It is very unlikely that 
the current findings occurred by chance as they have been replicated in completely 
separate cohorts, and the direction of the effect is consistent with previous in vivo and 
in vitro research [18,25-28] investigating P2X7R SNPs and bone phenotypes. 
rs2230912 and rs3751143 were not in Hardy Weinberg equilibrium in the military 
cohort. Since the genotyping method is reliable, genotyping error is very unlikely. 
The reasons for the disequilibrium may include non-random mating or chance 
findings. Since the direction of association between rs3751143 and stress fracture 
injury was the same in the military population, elite athletes and previous bone 
phenotypic studies [34,35], the disequilibrium seems unlikely to have influenced the 
outcome. The call rates (Table 2) for the alleles are lower than expected, this is due to 
an inadequate type of volume of sample being provided rather than SNP measurement 
issues.      
In the athlete cohort, the stress fracture group were older at sample collection and at 
the age of becoming elite compared with the non-stress fracture control group (Table 
1). Despite this, the average age of the non-stress fracture group was higher than the 
average age at which stress fracture injury occurred (19.9±3.9y). The age at reaching 
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elite status being higher in the stress fracture group (Table 1) raises the possibility that 
the skeletal adaptations that take place as a result of increased training at a younger 
age [36,37] are beneficial for stress fracture prevention [38]. However, excessive 
increases in training loads have also been related to stress fracture occurrence [39], 
making it difficult to draw a definitive cause of injury from the present study. The 
retrospective study design may have introduced recall bias however, this would be 
minimal as stress fracture injuries have a measurable impact in time of absence from 
training. Future studies should investigate P2X7R SNP associations with specific 
anatomical locations of stress fracture injury and attempt to control for variables, such 
as age and training parameters.     
 
In conclusion, two functional SNPs within P2X7R gene are independently associated 
with stress fracture injury in two separate cohorts of healthy, exercising individuals, 
although the significant associations did not persist after performing multiple 
comparisons testing. The precise mechanism by which these mutations may influence 
stress fracture risk is unknown, but may include decreased sensitivity of bone to 
mechanical loading or decreased osteoclast apoptosis. The preliminary results of this 
trend for an association between gain of function and loss of function polymorphisms 
in the P2X7R gene and stress fracture risk needs to be validated in a larger stress 
fracture population. 
 
Acknowledgements: 
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Table 1. Characteristics of military personnel and elite athletes with and without 
radiologically confirmed stress fracture injuries. *denotes a significance level of 
P<0.05, ** P<0.01. 
 
Table 2. Call rate and minor allele frequency (MAF) of SNPs analysed in stress 
fracture and non-stress fracture groups. 
 
Table 3. P2X7R genotype distribution (percentage) and allele frequency of stress 
fracture cases and controls in military personnel and elite athletes. P values are the 
result of comparisons between genotype and allele frequencies between the stress 
fracture and non-stress fracture cohorts. *denotes a significant difference when cases 
were compared to controls (P<0.05). 
 
Table 4. P2X7R genotype distribution and allele frequency in elite athletes with 
multiple stress fractures. P values are the result of comparisons between genotype and 
allele frequencies between the multiple stress fracture and non-stress fracture cohorts. 
*Indicates significance at P<0.05 in comparison to the non-stress fracture elite athlete 
group. 
 
Figure 1. (A) Distribution of rs1718119 alleles in military personnel and elite athlete 
stress fracture and non-stress fracture groups. *Indicates significance at P<0.05 in 
comparison to the matched non-stress fracture group. (B) Distribution of rs3751143 
alleles in military personnel and elite athlete stress fracture and non-stress fracture 
groups. * Indicates significance at P < 0.05 in comparison to the matched non-stress 
fracture group. 
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